Product Details
Administration
IV Infusion
Product Name
Priunta Trastuzumab 440mg Injection
Composition
Trastuzumab 440mg
Protein Type
Recombinant IgG1 Monoclonal Antibody
Therapeutic Target
HER2 Receptor
Clinical Use
HER2-Positive Breast Cancer
Additional Indication
HER2-Positive Gastric Cancer
Presentation
Single-Dose Vial
Reconstitution
Bacteriostatic Water For Injection
Protection
Keep Protected From Light
Prescription
Oncologist Supervision Required
Manufacturer
Reliance Life Sciences Pvt. Ltd.
Marketer
Abbott Healthcare Pvt. Ltd.
We provide Priunta Trastuzumab 440mg Injection, a lyophilized powder containing 440mg of Trastuzumab, a recombinant IgG1 monoclonal antibody. This product is for IV infusion, packaged in a single vial with a diluent volume of 20ml. Suitable for manufacturers, exporters, and suppliers, it must be stored at 2°C–8°C for optimal efficacy. With concrete specifications and measurable details, our product ensures precise dosing and administration for effective treatment. Trust in Priunta Trastuzumab 440mg Injection for reliable results in the medical field.